HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthew B Lawrenz Selected Research

Type V Secretion Systems

7/2013Acquisition of omptin reveals cryptic virulence function of autotransporter YapE in Yersinia pestis.
11/2011Expression during host infection and localization of Yersinia pestis autotransporter proteins.
1/2009A novel autotransporter adhesin is required for efficient colonization during bubonic plague.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matthew B Lawrenz Research Topics

Disease

11Infections
01/2022 - 05/2003
7Plague (Bubonic Plague)
11/2021 - 01/2009
2Bacterial Infections (Bacterial Infection)
11/2021 - 08/2021
2Pneumonia (Pneumonitis)
08/2021 - 08/2020
2Inflammation (Inflammations)
01/2020 - 01/2018
2Lyme Disease (Disease, Lyme)
08/2003 - 06/2002
1Lung Injury
08/2020
1Lung Neoplasms (Lung Cancer)
01/2018
1Silicosis
01/2018

Drug/Important Bio-Agent (IBA)

3Type V Secretion SystemsIBA
07/2013 - 01/2009
2IronIBA
01/2022 - 11/2021
2SiderophoresIBA
01/2022 - 11/2021
2ZincIBA
11/2021 - 01/2017
2Meropenem (Merrem)FDA LinkGeneric
08/2021 - 08/2020
2Anti-Bacterial Agents (Antibiotics)IBA
08/2021 - 08/2020
2Leukotriene B4IBA
01/2020 - 01/2018
2Subunit VaccinesIBA
10/2019 - 09/2014
2VaccinesIBA
10/2019 - 09/2014
2Proteins (Proteins, Gene)FDA Link
01/2019 - 11/2011
1yersiniabactinIBA
11/2021
1ManganeseIBA
11/2021
1Trace Elements (Biometals)IBA
11/2021
1Pharmaceutical PreparationsIBA
08/2021
1GelsolinIBA
08/2020
1Carbapenems (Carbapenem Antibiotics)IBA
08/2020
1LipidsIBA
01/2020
1Biological Warfare AgentsIBA
10/2019
1Aluminum Hydroxide (Algeldrate)FDA Link
10/2019
1InflammasomesIBA
01/2018
1Silicon Dioxide (Silica)FDA LinkGeneric
01/2018
14- (2,3- dihydro- 1,4- benzodioxin- 6- yl)- 2,4- dihydro- 5- ((5- nitro- 2- thiazolyl)thio)- 3H- 1,2,4- triazol- 3- oneIBA
01/2018
1MetalsIBA
07/2017
1aluminum sulfate (alum)IBA
09/2014
1Recombinant Fusion ProteinsIBA
09/2014
1Complement System Proteins (Complement)IBA
08/2003
1NicotinamidaseIBA
05/2003
1Lipoproteins (Lipoprotein)IBA
06/2002
1Surface Antigens (Surface Antigen)IBA
06/2002

Therapy/Procedure

4Therapeutics
08/2021 - 01/2010
1Phage Therapy
08/2021
1Treatment Delay
08/2021